Andrew G. Iwach, MD
Associate Clinical Professor
University of California, San Francisco
San Francisco, California
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Andrew G. Iwach, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Belkin Lasers, and OMIC. Shareholder: Eyenovia
John Flanagan, PhD, DSc, FCOptom, FAAO, FARVO has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Carl Zeiss Meditec. Advisory Board and Shareholder: Zilia.
J. Michael Jumper, MD has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: EyeBio. Speakers Bureau: Dutch Ophthalmic Research. Grant/Research Support: Genentech, Novartis, Regeneron, RegenXBio, and Boehringer Ingelheim.
L. Jay Katz has had a financial relationship or affiliation with the following ineligible companies in the form of Speakers Bureau: Allergan, Shareholder: Glaukos, Mati Pharma, Olleyes, and Aerie Pharmaceuticals.
Shan Lin, MD has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Aerie Pharmaceuticals, Iridex Corporation, and Santen Pharmaceuticals. Speakers Bureau: Aerie Pharmaceuticals, Iridex Corporation, and Bausch + Lomb.
Danica J. Marrelli, OD, FAAO has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Aerie Pharmaceuticals, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ivantis, and Santen. Speakers Bureau: Aerie Pharmaceuticals, Bausch + Lomb, and Carl Zeiss Meditec.
Terri Pickering, MD has no financial relationships with ineligible companies
Sunita Radhakrishnan, MD has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Netra Systems
Robert L. Stamper, MD has had a financial relationship or affiliation with the following ineligible companies in the form of Advisory Board: Inject Sense and Smartlens.
Ruth D. Williams, MD has no financial relationships with ineligible companies.
The Evolve and Glaucoma Research and Education Group staff, planners and peer reviewer have no financial relationships with ineligible companies.
